DNA Vaccine Market Size, Growth, Analysis, Trends & Forecast to 2022 DNA Vaccine Market Size, Growth, Analysis 2017 | Page 2

The study has publicized that though the numbers of DNA vaccines that target the human clinical
segment are relatively fewer in number, however due to high sales of these vaccines, the DNA
vaccine market is estimated to reach US$ 7 Billion by the end of 2016.
The report also contains detailed and in-depth analysis of the segmentation of the DNA vaccines
market based on types of DNA vaccines, therapeutic indication, end-users, and geography. Based
on the type, the DNA vaccines market is divided into recombinant protein and genetic. In 2016,
recombinant protein segment is estimated to account for largest share in the market. This large
share is attributed to the presence of high number of recombinant protein vaccines in the market.
Based on end-user, the report segments the market into human and animal. The majority of DNA
vaccines available in the market are targeted for humans. Moreover, the strong pipeline of human
targeted vaccines is likely to aid the market growth.
Related reports by Radiant Insights:
http://www.radiantinsights.com/catalog/healthcare
Based on geography, the report further divides the market into four regions, namely, North
America, Europe, Asia-Pacific, and Rest of the World. North America is the largest market for DNA
vaccines. The large share of the market is attributed to government's initiatives to immunize
citizens, coupled with high awareness regarding the benefits of genetic vaccines targeted towards
animals. The Asia-Pacific region is slated to witness the highest growth in the forecasted period.
This growth is likely to be driven by rising awareness of people regarding the advantages of
immunization against HPV and Hepatitis B.
The report also includes pipeline analysis based on the type of phase, therapeutic indications, and
type of diseases for which the vaccines have been designed, such as infectious and vector borne
diseases, and various types of cancers.
Major players in the DNA Vaccines market are also profiled with company overview, financial
overview, product portfolios, recent developments, and strengths and weaknesses. The last section
of the report discusses about the recommendations which could help the DNA vaccine market grow
at a faster pace. Conclusively, the research will prove to be a useful resource for all debut makers
in DNA vaccine industry, and potential investors.
Table of Contents
1. Analyst View
2. Research Methodology
3. DNA Vaccine - An Introduction
4. Drivers & Challenges
Follow Us: